There’s upcoming IPOs this week that traders are going to want to keep an eye on and we’re helping with a handy list.
Initial public offerings (IPOs) seeing companies offering up shares of their stock to the public market. With it comes extra activity that can result in shares rising or falling upon their debut.
Let’s jump into the upcoming IPOs this week below!
Upcoming IPOs This Week: Monday
2seventy bio (TSVTV)
An oncology spinoff of bluebird bio focused on cancer therapies.
Bluebird bio (BLUEV)
Bluebird bio (NASDAQ:BLUE) will switch to BLUEV shares after the spinoff of 2seventy bio.
Upcoming IPOs This Week: Wednesday
Stronghold Digital Mining (SDIG)
Bitcoin mining company powered by wholly-owned coal refuse power plants.
Upcoming IPOs This Week: Thursday
Enfusion (ENFN)
Provides cloud-based investment management software.
P10 (PX)
Provides private investment solutions to alternative asset managers.
Portillo’s (PTLO)
Fast casual restaurant chain known for its Chicago-style hot dogs.
Ventyx Biosciences (VTYX)
Phase 1 biotech developing selective therapies for inflammatory and autoimmune diseases.
Vita Coco (COCO)
Makes Vita Coco coconut water and other ready-to-drink beverages.
Winc (WBEV
Produces and distributes wine in the US.
Upcoming IPOs This Week: Friday
Aris Water Solutions (ARIS)
Operates a water pipeline for the oil and gas fracking industry.
Investors looking for more stock market news from today are going to want to keep reading!
We’ve got all the stock news traders need today with our daily coverage of the market. That includes DraftKings (NASDAQ:DKNG) making NFT plans, FuelCell Energy (NASDAQ:FCEL) pushing shares higher, as well as the FDA news slamming MannKind (NASDAQ:MNKD) stock today. You can find out all about these matters at the following links!
More Stock Market News for Monday
- DraftKings NFTs Partnership Puts Polygon Crypto, DKNG Stock in Focus
- The FuelCell Energy Chatter That Has FCEL Stock Trending Today
- MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
